Coronavirus Infection in Neonates: Neurodevelopmental Outcomes at 18 Months of Age

Background. Although most neonates with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection experience only mild disease, its impact on neurodevelopmental outcomes is unknown. This study aimed to assess the 18-month neurodevelopmental outcomes of infants who had SARS-CoV-2 infecti...

Full description

Saved in:
Bibliographic Details
Main Authors: Mariam Ayed, Zainab Alsaffar, Zainab Bahzad, Yasmeen Buhamad, Ali Abdulkareem, Alaa AlQattan, Alia Embaireeg, Mais Kartam, Hessa Alkandari
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2023/6140085
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849306725454184448
author Mariam Ayed
Zainab Alsaffar
Zainab Bahzad
Yasmeen Buhamad
Ali Abdulkareem
Alaa AlQattan
Alia Embaireeg
Mais Kartam
Hessa Alkandari
author_facet Mariam Ayed
Zainab Alsaffar
Zainab Bahzad
Yasmeen Buhamad
Ali Abdulkareem
Alaa AlQattan
Alia Embaireeg
Mais Kartam
Hessa Alkandari
author_sort Mariam Ayed
collection DOAJ
description Background. Although most neonates with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection experience only mild disease, its impact on neurodevelopmental outcomes is unknown. This study aimed to assess the 18-month neurodevelopmental outcomes of infants who had SARS-CoV-2 infection as neonates. Methods. The authors conducted a prospective cohort study of neonates diagnosed with SARS-CoV-2 infection from June 2020 to December 2020 through nasopharyngeal coronavirus disease 2019 (COVID-19). A total of 58 neonates were identified from the Kuwait National COVID-19 Registry and enrolled. Historical controls were selected from the neonatal follow-up registry and matched in a 2 : 1 ratio based on sex and gestational age. When the subjects were 18 months of age, their neurodevelopmental outcomes were assessed by two trained assessors using the Bayley Scales of Infant and Toddler Development-3rd Edition (BSID-III). Results. Forty children diagnosed with SARS-CoV-2 infection were included in the final analysis. The median age at infection was 18 days (range: 10–26 days). Eighteen (45%) patients were asymptomatic, 15 (37.5%) had a sepsis-like presentation, 5 (12.5%) exhibited respiratory distress, and 2 (5%) had a multisystem inflammatory syndrome in children (MIS-C)-like presentation. At the 18 months follow-up, only one child showed a severe developmental delay and one child had a language delay. BSID-III outcomes did not differ significantly between the SARS-CoV-2-infected and control groups. Conclusions There was no difference in neurodevelopmental outcomes at 18 months in children infected with SARS-CoV-2 compared with controls, although longer neurodevelopmental follow-up studies are required.
format Article
id doaj-art-2d9cc81937ce4498baada4df9e851852
institution Kabale University
issn 1918-1493
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases and Medical Microbiology
spelling doaj-art-2d9cc81937ce4498baada4df9e8518522025-08-20T03:55:00ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1918-14932023-01-01202310.1155/2023/6140085Coronavirus Infection in Neonates: Neurodevelopmental Outcomes at 18 Months of AgeMariam Ayed0Zainab Alsaffar1Zainab Bahzad2Yasmeen Buhamad3Ali Abdulkareem4Alaa AlQattan5Alia Embaireeg6Mais Kartam7Hessa Alkandari8Neonatal DepartmentPediatric DepartmentPediatric DepartmentPediatric DepartmentPediatric DepartmentPediatric DepartmentNeonatal DepartmentPediatric DepartmentPediatric DepartmentBackground. Although most neonates with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection experience only mild disease, its impact on neurodevelopmental outcomes is unknown. This study aimed to assess the 18-month neurodevelopmental outcomes of infants who had SARS-CoV-2 infection as neonates. Methods. The authors conducted a prospective cohort study of neonates diagnosed with SARS-CoV-2 infection from June 2020 to December 2020 through nasopharyngeal coronavirus disease 2019 (COVID-19). A total of 58 neonates were identified from the Kuwait National COVID-19 Registry and enrolled. Historical controls were selected from the neonatal follow-up registry and matched in a 2 : 1 ratio based on sex and gestational age. When the subjects were 18 months of age, their neurodevelopmental outcomes were assessed by two trained assessors using the Bayley Scales of Infant and Toddler Development-3rd Edition (BSID-III). Results. Forty children diagnosed with SARS-CoV-2 infection were included in the final analysis. The median age at infection was 18 days (range: 10–26 days). Eighteen (45%) patients were asymptomatic, 15 (37.5%) had a sepsis-like presentation, 5 (12.5%) exhibited respiratory distress, and 2 (5%) had a multisystem inflammatory syndrome in children (MIS-C)-like presentation. At the 18 months follow-up, only one child showed a severe developmental delay and one child had a language delay. BSID-III outcomes did not differ significantly between the SARS-CoV-2-infected and control groups. Conclusions There was no difference in neurodevelopmental outcomes at 18 months in children infected with SARS-CoV-2 compared with controls, although longer neurodevelopmental follow-up studies are required.http://dx.doi.org/10.1155/2023/6140085
spellingShingle Mariam Ayed
Zainab Alsaffar
Zainab Bahzad
Yasmeen Buhamad
Ali Abdulkareem
Alaa AlQattan
Alia Embaireeg
Mais Kartam
Hessa Alkandari
Coronavirus Infection in Neonates: Neurodevelopmental Outcomes at 18 Months of Age
Canadian Journal of Infectious Diseases and Medical Microbiology
title Coronavirus Infection in Neonates: Neurodevelopmental Outcomes at 18 Months of Age
title_full Coronavirus Infection in Neonates: Neurodevelopmental Outcomes at 18 Months of Age
title_fullStr Coronavirus Infection in Neonates: Neurodevelopmental Outcomes at 18 Months of Age
title_full_unstemmed Coronavirus Infection in Neonates: Neurodevelopmental Outcomes at 18 Months of Age
title_short Coronavirus Infection in Neonates: Neurodevelopmental Outcomes at 18 Months of Age
title_sort coronavirus infection in neonates neurodevelopmental outcomes at 18 months of age
url http://dx.doi.org/10.1155/2023/6140085
work_keys_str_mv AT mariamayed coronavirusinfectioninneonatesneurodevelopmentaloutcomesat18monthsofage
AT zainabalsaffar coronavirusinfectioninneonatesneurodevelopmentaloutcomesat18monthsofage
AT zainabbahzad coronavirusinfectioninneonatesneurodevelopmentaloutcomesat18monthsofage
AT yasmeenbuhamad coronavirusinfectioninneonatesneurodevelopmentaloutcomesat18monthsofage
AT aliabdulkareem coronavirusinfectioninneonatesneurodevelopmentaloutcomesat18monthsofage
AT alaaalqattan coronavirusinfectioninneonatesneurodevelopmentaloutcomesat18monthsofage
AT aliaembaireeg coronavirusinfectioninneonatesneurodevelopmentaloutcomesat18monthsofage
AT maiskartam coronavirusinfectioninneonatesneurodevelopmentaloutcomesat18monthsofage
AT hessaalkandari coronavirusinfectioninneonatesneurodevelopmentaloutcomesat18monthsofage